The dimerization/repression domain of RFX1 is related to a conserved region of its yeast homologues Crt1 and Sak1: A new function for an ancient motif

Journal of Molecular Biology

Volumn 294, Issue 1, 1999, Pages 121-137

  Katan Khaykovich, Yael ^a   Spiegel, Ivo ^a   Shaul, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Dimerization; EMSA; Molecular evolution; RFX family; Transcriptional repression

Indexed keywords

DNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIMERIZATION; DNA PROTEIN COMPLEX; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE; TRANSCRIPTION REGULATION;

ANIMALIA; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE;

EID: 0033585025     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3245     Document Type: Article

References (49)

1. Agami R., Shaul Y. The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFX1, a protein that binds the enhancers of several viruses and cell-cycle regulated genes. Oncogene. 16:1998;1779-1788.
2. Baxevanis A. D., Vinson C. R. Interactions of coiled coils in transcription factors: where is the specificity? Curr. Opin. Genet. Dev. 3:1993;278-285.
3. Ben-Levy R., Faktor O., Berger I., Shaul Y. Cellular factors that interact with the hepatitis B virus enhancer. Mol. Cell Biol. 9:1989;1804-1809.
4. Blake M., Niklinski J., Zajac-Kaye M. Interactions of the transcription factors MIBP1 and RFX1 with the EP element of the hepatitis B virus enhancer. J. Virol. 70:1996;6060-6066.
5. Bolwig G. M., Hearing P. Interaction of nuclear factor EF-1A with the polyomavirus enhancer region. J. Virol. 65:1991;1884-1892.
6. Buckwold V. E., Chen M., Ou J.-H. Interaction of transcription factors RFX1 and MIBP1 with the gamma motif of the negative regulatory element of the hepatitis B virus core promoter. Virology. 227:1997;515-518.
7. Burbach K. M., Poland A., Bradfield C. A. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl Acad. Sci. USA. 89:1992;8185-8189.
8. David E., Garcia A. D., Hearing P. Interaction of EF-C/RFX-1 with the inverted repeat of viral enhancer regions is required for transactivation. J. Biol. Chem. 270:1995;8353-8360.
9. Dikstein R., Faktor O., Ben-Levy R., Shaul Y. Functional organization of the hepatitis B virus enhancer. Mol. Cell Biol. 10:1990;3682-3689.
10. Dikstein R., Heffetz D., Ben-Neriah Y., Shaul Y. c-abl has a sequence-specific enhancer binding activity. Cell. 69:1992;751-757.
11. Dikstein R., Agami R., Heffetz D., Shaul Y. p140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues. Proc. Natl Acad. Sci. USA. 93:1996;2387-2391.
12. Emery P., Durand B., Mach B., Reith W. RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucl. Acids Res. 24:1996a;803-807.
13. Emery P., Strubin M., Hofmann K., Bucher P., Mach B., Reith W. A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity. Mol. Cell Biol. 16:1996b;4486-4494.
14. Fawell S. E., Lees J. A., White R., Parker M. G. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell. 60:1990;953-962.
15. Greschik H., Wurtz J.-M., Hublitz P., Kohler F., Moras D., Schule R. Characterization of the DNA-binding and dimerization properties of the nuclear orphan receptor germ cell nuclear factor. Mol. Cell Biol. 19:1999;690-703.
16. Herrero-Sanchez C., Reith W., Silacci P., Mach B. The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters. Mol. Cell Biol. 12:1992;4076-4083.
17. Huang M., Zhou Z., Elledge S. J. The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor. Cell. 94:1998;595-605.
18. Iwama A., Pan J., Zhang P., Reith W., Mach B., Tenen D. G., Sun Z. Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains. Mol. Cell Biol. 19:1999;3940-3950.
19. Jones N. Transcriptional regulation by dimerization: two sides to an incestuous relationship. Cell. 61:1990;9-11.
20. Katan Y., Agami R., Shaul Y. The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities. Nucl. Acids Res. 25:1997;3621-3628.
21. Katan-Khaykovich Y., Shaul Y. RFX1, a single DNA-binding protein with a split dimerization domain, generates alternative complexes. J. Biol. Chem. 273:1998;24504-24512.
22. Kouskoff V., Mantovani R. M., Candeias S. M., Dorn A., Staub A., Lisowska-Grospierre B., Griscelli C., Benoist C. O., Mathis D. J. NF-X, a transcription factor implicated in MHC class II gene regulation. J. Immunol. 146:1991;3197-3204.
23. Labrie C., Lee B. H., Mathews M. B. Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A- responsive element of the human proliferating cell nuclear antigen promoter. Nucl. Acids Res. 23:1995;3732-3741.
24. Lee B. H., Liu M., Mathews M. B. Regulation of the human proliferating cell nuclear antigen promoter by the adenovirus E1A-associated protein p107. J. Virol. 72:1998;1138-1145.
25. Liu M., Lee B. H., Mathews M. B. Involvement of RFX1 protein in the regulation of the human proliferating cell nuclear antigen promoter. J. Biol. Chem. 274:1999;15433-15439.
26. Mangelsdorf D. J., Evans R. M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
27. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. et al. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
28. Moras D., Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10:1998;384-391.
29. Ori A., Zauberman A., Doitsh G., Paran N., Oren M., Shaul Y. p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53. EMBO J. 17:1998;544-553.
30. Ostapchuk P., Diffley J. F., Bruder J. T., Stillman B., Levine A. J., Hearing P. Interaction of a nuclear factor with the polyomavirus enhancer region. Proc. Natl Acad. Sci. USA. 83:1986;8550-8554.
31. Ostapchuk P., Scheirle G., Hearing P. Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region. Mol. Cell Biol. 9:1989;2787-2797.
32. Perlmann T., Umesono K., Rangarajan P. N., Forman B. M., Evans R. M. Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors. Mol. Endocrinol. 10:1996;958-966.
33. Reinhold W., Emens L., Itkes A., Blake M., Ichinose I., Zajac-Kaye M. The myc intron-binding polypeptide associates with RFX1 in vivo and binds to the major histocompatibility complex class II promoter region, to the hepatitis B virus enhancer, and to regulatory regions of several distinct viral genes. Mol. Cell Biol. 15:1995;3041-3048.
34. Reith W., Barras E., Satola S., Kobr M., Reinhart D., Herrero-Sanchez C., Mach B. Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation. Proc. Natl Acad. Sci. USA. 86:1989;4200-4204.
35. Reith W., Herrero-Sanchez C., Kobr M., Silacci P., Berte C., Barras E., Fey S., Mach B. MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain. Genes Dev. 4:1990;1528-1540.
36. Reith W., Ucla C., Barras E., Gaud A., Durand B., Herrero-Sanchez C., Kobr M., Mach B. RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol. Cell Biol. 14:1994;1230-1244.
37. Safrany G., Perry R. P. Transcription factor RFX1 helps control the promoter of the mouse ribosomal protein-encoding gene rpL30 by binding to its alpha element. Gene. 132:1993;279-283.
38. Safrany G., Perry R. P. The relative contributions of various transcription factors to the overall promoter strength of the mouse ribosomal protein L30 gene. Eur. J. Biochem. 230:1995;1066-1072.
39. Schulman I. G., Juguilon H., Evans R. M. Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol. Cell Biol. 16:1996;3807-3813.
40. Siegrist C. A., Mach B. Antisense oligonucleotides specific for regulatory factor RFX-1 inhibit inducible but not constitutive expression of all major histocompatibility complex class II genes. Eur. J. Immunol. 23:1993;2903-2908.
41. Siegrist C. A., Durand B., Emery P., David E., Hearing P., Mach B., Reith W. RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer. Mol. Cell Biol. 13:1993;6375-6384.
42. Steimle V., Durand B., Barras E., Zufferey M., Hadam M. R., Mach B., Reith W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1995;1021-1032.
43. Tsang S. Y., Nakanishi M., Peterlin B. M. B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene. Proc. Natl Acad. Sci. USA. 85:1988;8598-8602.
44. Tsang S. Y., Nakanishi M., Peterlin B. M. Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors. Mol. Cell Biol. 10:1990;711-709.
45. Vivat V., Zechel C., Wurtz J. M., Bourguet W., Kagechika H., Umemiya H., Shudo K., Moras D., Gronemeyer H., Chambon P. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J. 16:1997;5697-5709.
46. Weisinger G., Remmers E. F., Hearing P., Marcu K. B. Multiple negative elements upstream of the murine c-myc gene share nuclear factor binding sites with SV40 and polyoma enhancers. Oncogene. 3:1988;635-646.
47. White R., Sjoberg M., Kalkhoven E., Parker M. G. Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J. 16:1997;1427-1435.
48. Wu S. Y., McLeod M. The sak1+gene of Schizosaccharomyces pombe encodes an RFX family DNA- binding protein that positively regulates cyclic AMP-dependent protein kinase-mediated exit from the mitotic cell cycle. Mol. Cell Biol. 15:1995;1479-1488.
49. Zhang X. Y., Asiedu C. K., Supakar P. C., Khan R., Ehrlich K. C., Ehrlich M. Binding sites in mammalian genes and viral gene regulatory regions recognized by methylated DNA-binding protein. Nucl. Acids Res. 18:1990;6253-6260.